Cancer Research Antibodies

We offer thousands of primary antibodies for use in cancer research. Whether you’re research is focused on metastasis, proliferative signaling, apoptosis, autophagy, metabolism, inflammation, tumor suppressors or any other cancer-related research area, we have a broad selection of research antibodies to help ensure your success. Use our antibody search tool below to find the right Invitrogen™ antibody for your research.


Already know your cancer research target of interest?

Find antibodies of interest using the search tool below. Then filter the results by target or host species, monoclonal or polyclonal antibody type, and other criteria.


Featured cancer research antibody categories

There are at least three distinct mitogen-activated protein kinase (MAPK) signaling modules which mediate extracellular signals into the nucleus to turn on the responsive genes in mammalian cells, including ERK, JNK, and p38 kinase. The MAPK signaling pathway is essential in regulating many cellular processes including inflammation, cell differentiation, cell proliferation and death. Use antibodies to study the role of MAPK pathway in cancer, immune disorders and neurodegenerative diseases.


Related application and cell analysis categories

Analyze how cell signaling pathways are disrupted in cancer by accurately quantifying intracellular and extracellular proteins using protein analysis tools designed for single or multiplex cancer biomarker analysis.

Evaluate the hallmarks of cancer with our many cell analysis assays, which have been validated on multiple instrument platforms and applications: microscopy, flow cytometry, microplate readers, and high-content screening.

Visualize intracellular changes in cancer cells right on your benchtop using our assays and imaging equipment. You can also visualize cell cycle progression in live cells.

Identify quiescent cancer stem cells and determine their role in metastasis and therapeutic resistance.

Identify, track, and analyze cancer cell signaling events in individual cancer cells using flow cytometry for cell proliferation, cell cycle, apoptosis, and immunophenotyping and detect rare cellular events such as human circulating endothelial cells.